3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
9
Melanoma
4
Ganglioneuroblastoma
4
Triple Negative Breast Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Transplant-Related Hematologic Malignancy
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Alveolar Soft Part
1
Recurrence
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hodgkin Disease
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Interventions
fludarabine phosphate
3
Whole-Body Irradiation
3
Tacrolimus
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Melphalan
3
Cyclophosphamide
3
Busulfan
3
Biopsy
3
fludarabine
2
Patient Reported Outcome Measures
2
Mesna
2
Colposcopy
2
Aminolevulinic Acid
2
tirbanibulin
1
ruxolitinib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Thalidomide
1
Tamoxifen
1
Sirolimus
1
Robotic Surgical Procedures
1
Radiotherapy, Intensity-Modulated
1
Pregnancy Tests
1
Nivolumab
1
Methotrexate
1
Immunohistochemistry
1
Hysterectomy
1
Human Papillomavirus DNA Tests
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precancerous Conditions
×
sargramostim
×
1 year
×
Clear all
No trials found.